Table 1

Demographic characteristics and mechanical ventilation parameters of the control group









Fluid balance (ml)
Diuresis (ml)










Sex
Age
Diagnosis
Mode
FiO2 (%)
VE (L/min)
Vasoactive drugs
Tracheal secretion
24 hours
Study
24 hours
Study

F
70
Mediastinal tumor resection
AMV
40
11.7
-
S. viridans
+31
+233
1150
75
M
20
Head trauma
VAPS
45
9.6
-
P. aeruginosa
+78
-10
2350
400
M
20
Head trauma
VAPS
40
9.2
-
P. aeruginosa S. aureus
+341
+83
2450
400
M
63
Cerebrovascular accident, heart failure, osteomyelitis
VAPS
46
10.5
Dobutamine
A. calcoaceticus P. aeruginosa S. aureus
-1310
-154
3180
480
M
47
Lung neoplasm
SIMV
40
9.7
Dobutamine
-
+564
+321
1920
120
M
76
Lung neoplasm, pneumonia
AMV
36
8.7
Dobutamine Dopamine
P. aeruginosa X. maltophilia
+1408
+132
780
100
M
66
Heart failure, pneumonia, pulmonar lobectomy
PC
50
8.7
Dobutamine
A. calcoaceticus
+534
+373
2300
120
M
22
Craniotomy, pneumonia
AMV
40
9.4
-
A. calcoaceticus E. cloacae
+1411
+171
2400
140
M
41
Hyperosmolar coma, cerebrovascular accident
PC/SIMV
40
10.7
-
A. baumanii S. viridans S. coagulase neg
-518
+86
550
150
M
61
Lung neoplasm, COPD, acute renal insufficiency
PS
45
11.7
Dobutamine
S. marcescens A. baumanii X. maltophilia
+1871
+183
60
20
F
58
Drug intoxication, pneumonia
PC/SIMV
40
7.7
-
S. aureus
+286
-98
2000
171
M
74
Pulmonary tumor resection
AMV
30
8.3
-
-
-462
+133
1650
125
M
51
Respiratory failure
PC/SIMV
40
10.5
Noradrenaline
-
+1452
-59
2000
720
F
23
Thyroidectomy
SIMV
40
5.0
-
-
+3551
+290
2570
200
Mean ± SD
50 ± 20


40 ± 4
9.4 ± 1.7


671 ± 1169
82 ± 212
1824 ± 847
258 ± 218

Abbreviations: AMV, assisted mechanical ventilation; COPD, chronic obstructive pulmonary disease; FiO2, fraction of inspired oxygen; PC, pressure-controlled ventilation; PS, pressure-support ventilation; SIMV, synchronized intermittent mandatory ventilation; VAPS, volume-assured pressure support, VE, minute volume. *P < 0.05.

Kondo et al. Critical Care 2002 6:81   doi:10.1186/cc1458